Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Benchmarking Report

To paint a picture of the current situation of IPF care in Europe, EU-PFF has developed a Benchmarking Report to identify gaps in care, compare countries’ performances and encourage the replication of best practices. What is more, the Benchmarking Report comes with concrete recommendations on how patient care can be improved both for those living with IPF and their families.

The first version covered 13 countries, and in 2020 we have expanded the second edition to include four additional countries.

The updated Report is a major achievement for our community.

The content of the Benchmarking Report represents the views of the authors only and is their sole responsibility. 

This Report is not intended as an exhaustive or scientific review of the care and management of IPF in Europe.

The interviews on which this Report is based have provided useful insights into some of the issues affecting a selection of patients living with IPF and their families. They also supported the identification of several discrepancies in IPF care within and between European countries.

Recognising that the Benchmarking Report only represents a snapshot of the IPF landscape in seventeen EU countries, the EU-PFF welcomes feedback.

The EU-PFF remembers Harry van der Haak and Maria Rigo who sadly passed away while we were working on this update. 

Their comments remain within the report with our gratitude for their inspiring advocacy work on behalf of their patient communities in Netherlands and Hungary.

Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche LTD and Galapagos NV financially supported the Benchmarking Report.